Pharming Group to Host Financial Results Webcast

Ticker: PHAR · Form: 6-K · Filed: Jun 24, 2025 · CIK: 1828316

Pharming Group N.V. 6-K Filing Summary
FieldDetail
CompanyPharming Group N.V. (PHAR)
Form Type6-K
Filed DateJun 24, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: earnings-call, investor-relations, financial-results

Related Tickers: PHAR

TL;DR

Pharming Group (PHAR) hosting earnings webcast July 1st - tune in for the deets.

AI Summary

Pharming Group N.V. announced on June 24, 2025, that it will host a webcast to discuss its financial results and business updates. The webcast is scheduled for July 1, 2025, at 2:00 PM CEST (8:00 AM EDT). Participants will include CEO Sijmen de Vries and CFO Derek van der Zwaag.

Why It Matters

This webcast provides investors with a direct update on the company's financial performance and strategic direction, offering insights into its future prospects.

Risk Assessment

Risk Level: low — This filing is a routine announcement of a financial results webcast, which typically carries low risk.

Key Players & Entities

  • Pharming Group N.V. (company) — Registrant
  • June 24, 2025 (date) — Announcement Date
  • July 1, 2025 (date) — Webcast Date
  • 2:00 PM CEST (time) — Webcast Time
  • 8:00 AM EDT (time) — Webcast Time
  • Sijmen de Vries (person) — CEO
  • Derek van der Zwaag (person) — CFO

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K filing is to furnish a press release dated June 24, 2025, announcing that Pharming Group N.V. will host a webcast to discuss its financial results and business updates.

When will the Pharming Group N.V. webcast take place?

The webcast will take place on July 1, 2025, at 2:00 PM CEST (8:00 AM EDT).

Who will participate in the webcast?

The webcast will feature CEO Sijmen de Vries and CFO Derek van der Zwaag.

What information will be discussed during the webcast?

The webcast will cover Pharming Group N.V.'s financial results and business updates.

What is the Commission File Number for Pharming Group N.V.?

The Commission File Number for Pharming Group N.V. is 001-39822.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on June 24, 2025 by Sijmen de Vries regarding Pharming Group N.V. (PHAR).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.